Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Net Income (2016 - 2025)

Historic Net Income for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to $108.6 million.

  • CorMedix's Net Income rose 400227.68% to $108.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.5 million, marking a year-over-year increase of 49500.26%. This contributed to the annual value of -$17.9 million for FY2024, which is 6252.03% up from last year.
  • As of Q3 2025, CorMedix's Net Income stood at $108.6 million, which was up 400227.68% from $19.8 million recorded in Q2 2025.
  • CorMedix's 5-year Net Income high stood at $108.6 million for Q3 2025, and its period low was -$14.5 million during Q1 2024.
  • Over the past 5 years, CorMedix's median Net Income value was -$7.4 million (recorded in 2021), while the average stood at $2.3 million.
  • As far as peak fluctuations go, CorMedix's Net Income plummeted by 6414.73% in 2022, and later soared by 400227.68% in 2025.
  • CorMedix's Net Income (Quarter) stood at -$7.8 million in 2021, then fell by 5.36% to -$8.2 million in 2022, then dropped by 18.7% to -$9.7 million in 2023, then skyrocketed by 238.18% to $13.5 million in 2024, then soared by 706.3% to $108.6 million in 2025.
  • Its Net Income was $108.6 million in Q3 2025, compared to $19.8 million in Q2 2025 and $20.6 million in Q1 2025.